These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 9701366

  • 1. Availability of PSC833, a substrate and inhibitor of P-glycoproteins, in various concentrations of serum.
    Smith AJ, Mayer U, Schinkel AH, Borst P.
    J Natl Cancer Inst; 1998 Aug 05; 90(15):1161-6. PubMed ID: 9701366
    [Abstract] [Full Text] [Related]

  • 2. Multidrug-resistance P-glycoprotein (MDR1) secretes platelet-activating factor.
    Raggers RJ, Vogels I, van Meer G.
    Biochem J; 2001 Aug 01; 357(Pt 3):859-65. PubMed ID: 11463358
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines.
    Fujimoto H, Higuchi M, Watanabe H, Koh Y, Ghosh AK, Mitsuya H, Tanoue N, Hamada A, Saito H.
    Biol Pharm Bull; 2009 Sep 01; 32(9):1588-93. PubMed ID: 19721237
    [Abstract] [Full Text] [Related]

  • 6. Inhibitory effects of a cyclosporin derivative, SDZ PSC 833, on transport of doxorubicin and vinblastine via human P-glycoprotein.
    Kusunoki N, Takara K, Tanigawara Y, Yamauchi A, Ueda K, Komada F, Ku Y, Kuroda Y, Saitoh Y, Okumura K.
    Jpn J Cancer Res; 1998 Nov 01; 89(11):1220-8. PubMed ID: 9914792
    [Abstract] [Full Text] [Related]

  • 7. Interaction of docetaxel ("Taxotere") with human P-glycoprotein.
    Shirakawa K, Takara K, Tanigawara Y, Aoyama N, Kasuga M, Komada F, Sakaeda T, Okumura K.
    Jpn J Cancer Res; 1999 Dec 01; 90(12):1380-6. PubMed ID: 10665657
    [Abstract] [Full Text] [Related]

  • 8. MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping.
    Smith AJ, van Helvoort A, van Meer G, Szabo K, Welker E, Szakacs G, Varadi A, Sarkadi B, Borst P.
    J Biol Chem; 2000 Aug 04; 275(31):23530-9. PubMed ID: 10918072
    [Abstract] [Full Text] [Related]

  • 9. Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems.
    Kawahara I, Kato Y, Suzuki H, Achira M, Ito K, Crespi CL, Sugiyama Y.
    Drug Metab Dispos; 2000 Oct 04; 28(10):1238-43. PubMed ID: 10997946
    [Abstract] [Full Text] [Related]

  • 10. Combined treatment of Bcl-2 antisense oligodeoxynucleotides (G3139), p-glycoprotein inhibitor (PSC833), and sterically stabilized liposomal doxorubicin suppresses growth of drug-resistant growth of drug-resistant breast cancer in severely combined immunodeficient mice.
    Lopes de Menezes DE, Hu Y, Mayer LD.
    J Exp Ther Oncol; 2003 Oct 04; 3(2):72-82. PubMed ID: 12822513
    [Abstract] [Full Text] [Related]

  • 11. Transport activity and surface expression of the Na+-Ca2+ exchanger NCX1 are inhibited by the immunosuppressive agent cyclosporin A and by the nonimmunosuppressive agent PSC833.
    Kimchi-Sarfaty C, Kasir J, Ambudkar SV, Rahamimoff H.
    J Biol Chem; 2002 Jan 25; 277(4):2505-10. PubMed ID: 11700317
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the major metabolites of verapamil as substrates and inhibitors of P-glycoprotein.
    Pauli-Magnus C, von Richter O, Burk O, Ziegler A, Mettang T, Eichelbaum M, Fromm MF.
    J Pharmacol Exp Ther; 2000 May 25; 293(2):376-82. PubMed ID: 10773005
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Trabectedin (ET-743, Yondelis) is a substrate for P-glycoprotein, but only high expression of P-glycoprotein confers the multidrug resistance phenotype.
    Beumer JH, Buckle T, Ouwehand M, Franke NE, Lopez-Lazaro L, Schellens JH, Beijnen JH, van Tellingen O.
    Invest New Drugs; 2007 Feb 25; 25(1):1-7. PubMed ID: 16633714
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.
    Baltes S, Gastens AM, Fedrowitz M, Potschka H, Kaever V, Löscher W.
    Neuropharmacology; 2007 Feb 25; 52(2):333-46. PubMed ID: 17045309
    [Abstract] [Full Text] [Related]

  • 20. Is aspirin a substrate of MDR1/P-glycoprotein?
    Singh R, Naik T, Nigam A, Chatterjee S, Rajanna P, Shen H, Iyer R.
    Xenobiotica; 2020 Oct 25; 50(10):1258-1264. PubMed ID: 32302241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.